Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in relapsed / refractory marginal zone lymphoma: Results from phase 1/2 BRUIN study Meeting Abstract
| Authors: | Patel, K.; Vose, J. M.; Nasta, S. D.; Brown, J. R.; Maddocks, K. J.; Woyach, J. A.; Shah, N. N.; Fakhri, B.; Tessoulin, B.; Ma, S.; Jagadeesh, D.; Lech-Maranda, E.; Coombs, C. C.; Patel, M.; Rhodes, J. M.; Ujjani, C. S.; Hoffmann, M. S.; Cheah, C. Y.; Munir, T.; Lewis, D.; Scarfo, L.; Eyre, T. A.; Alencar, A. J.; Cohen, J. B.; Zelenetz, A. D.; Tsai, D. E.; Li, M.; Bian, F.; Abada, P.; Zinzani, P. L. |
| Abstract Title: | Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in relapsed / refractory marginal zone lymphoma: Results from phase 1/2 BRUIN study |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 1660 |
| Language: | English |
| ACCESSION: | WOS:001159306706131 |
| DOI: | 10.1182/blood-2023-180048 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
